Clinical Trial: A Study to Assess the Efficacy and Safety of RO7965032 in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07851259) titled 'A Study to Assess the Efficacy and Safety of RO7965032 in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration' on Sept. 25.

Brief Summary: This study will assess the safety and efficacy of RO7965032 to address a significant unmet medical need in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD)

Study Start Date: Sept. 30

Study Type: INTERVENTIONAL

Condition: Geographic Atrophy Secondary to Age-Related Macular Degeneration

Intervention: DRUG: RO7965032

RO7965032 will be administered as per the schedule defined in the protocol.

DRUG: Placebo

Placebo wil...